For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

Young adults with kidney disease have a high risk of transitioning from peritoneal dialysis to hemodialysis due to infections ...

Chronic Kidney Disease (CKD) affects approximately 15% of U.S. adults and as many as 9 in 10 with CKD are unaware they have ...

In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...

According to the American Kidney Fund, kidney disease is growing at an alarming rate. It currently affects more than one in ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

African Americans face higher risks of kidney disease and endometriosis, yet awareness remains low. Learn key warning signs ...

Olympic gymnast Suni Lee detailed her emotional battle with an incurable kidney disease in a new essay for 'Women's Health' ...

Today, the American Kidney Fund (AKF) and MAVEN Project announced a new partnership that will support primary care clinicians, amplifying AKF and MAVEN Project’s shared commitment to addressing ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...